← Leaderboards
Nancy K Sweitzer
Brigham And Women'S Hospital
$1,333,767
Attributed
$2,359,733
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $745.1K · FY2005–18$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$2,359,733 · 5
By mechanism
U01$1,367,955 · 1
K23$594,910 · 1
R21$388,975 · 1
M01$7,893 · 2
Top collaborators
- Andrew E Arai2 shared
- Meredith Hay2 shared
- Lee Ryan2 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Kullervo Hynynen$20,293,002
- Leo Francis Buckley$1,123,217
- Gregory T Clement$4,242,636
- Clare M Tempany$31,151,323
- Susan S Redline$76,698,471
Others in their field
Top investigators on “Myocardium”
- Lynn A Sleeper · New England Research Institutes, Inc.$41,686,119
- Piero Anversa · New York Medical College$37,744,132
- Walter J Koch · Duke University$32,189,425
- Deepak Srivastava · J. David Gladstone Institutes$25,431,561
- Jianyi Zhang · University Of Alabama At Birmingham$23,901,556
- Ju Chen · University Of California, San Diego$23,492,230
Research focus
MyocardiumHuman Old Age (65+)Clinical ResearchGeriatricsHuman SubjectCongestive Heart FailureCardiac OutputHeart VentricleBlood PressureHemodynamicsHeart Disorder ChemotherapyHuman Therapy EvaluationHeart FunctionLeftMeasurementLeadMortality Vital StatisticsHeart FailureHospitalizationFailure (Biologic Function)EvaluationDesignArterial StiffnessElderly
Grant awards (11)
Evaluation of the Safety and Efficacy of Angiotensin 1-7 to Enhance Cognitive Function in Participants Undergoing Coronary Artery Bypass Graft (CABG) Surgery$622,890
U01 · FY2018 · HL · contact PI
Evaluation of the Safety and Efficacy of Angiotensin 1-7 to Enhance Cognitive Function in Participants Undergoing Coronary Artery Bypass Graft (CABG) Surgery$745,065
U01 · FY2017 · HL · contact PI
Reduced contractile reserve: a therapeutic target in heart failure with normal EF$185,625
R21 · FY2012 · HL · contact PI
Reduced contractile reserve: a therapeutic target in heart failure with normal EF$203,350
R21 · FY2011 · HL · contact PI
EFFECT OF AORTIC IMPEDANCE ON MYOCARDIAL RELAXATION$1,687
M01 · FY2007 · RR · contact PI
EFFECT OF AORTIC IMPEDANCE ON MYOCARDIAL RELAXATION$6,206
M01 · FY2006 · RR · contact PI
MECHANISMS OF DIASTOLIC HEART FAILURE IN AGING$108,810
K23 · FY2005 · AG
MECHANISMS OF DIASTOLIC HEART FAILURE IN AGING$112,050
K23 · FY2004 · AG
MECHANISMS OF DIASTOLIC HEART FAILURE IN AGING$112,050
K23 · FY2003 · AG
MECHANISMS OF DIASTOLIC HEART FAILURE IN AGING$121,500
K23 · FY2002 · AG
MECHANISMS OF DIASTOLIC HEART FAILURE IN AGING$140,500
K23 · FY2000 · AG